
ABSTRACT Objectives Pulsed dye laser (PDL) treatment for psoriasis has demonstrated its potential for treatment‐free remission periods exceeding 1 year. The mechanism leading to remission is not fully understood, but PDL is known to heat the vasculature in the skin. We hypothesized that heat diffuses from the vasculature to the surrounding environment, including perivascular nerves and T‐cells, leading to an interruption of the neurogenic inflammatory cycle that drives psoriasis. Methods We compared histological features of the vasculature, nerves, and leukocyte infiltrate in 120 biopsy sections (80 µm thick) from 20 patients, collected before and after two PDL treatments. The alterations in vasculature were categorized into three distinct classifications: papillary vasculature, reticular vasculature, and total vasculature. Nerve fibers were divided into free epidermal nerve fibers, perivascular nerve fibers around capillaries, and reticular nerves. The densities of these structures, as well as the volume of the epidermal and dermal leukocyte infiltrate, were calculated from the three‐dimensional (3D) fluorescence microscopy images. Results Two sessions of PDL treatment significantly reduced CD3 + leukocyte infiltrate in the skin. Furthermore, pruritus and epidermal thickness were also significantly reduced. Vascular and nerve fiber density did not significantly differ before and after two treatments. Conclusions Using 3D immunofluorescence microscopy to quantify T‐cells, vasculature and nerve fibers, we found that two PDL treatments were associated with a significant reduction in CD3 + T‐cells, even in patients whose clinical severity did not improve, while vascular and nerve fiber density remained unchanged. Perivascular heat diffusion and potential alterations in vascular integrity may contribute to this reduction, but this hypothesis requires confirmation in future studies.
ABSTRACT Objectives Dermatologic lasers and energy‐based devices (EBDs) are widely used in medical and cosmetic dermatology. Despite their effectiveness, complications may lead to medicolegal claims. This systematic review aimed to evaluate the global patterns and outcomes of medicolegal claims associated with dermatologic laser and energy‐based procedures. Methods A systematic review was conducted according to the PRISMA 2020 guidelines and registered in PROSPERO (CRD420261286979). PubMed, Scopus, the Cochrane Library, and Embase were searched from inception to November 2025 for studies reporting medico‐legal outcomes related to dermatologic laser or energy‐based procedures. Results Eighteen reports encompassing 5460 cases in their source datasets were included. Ten reports (1751 cases) primarily concerned laser and energy‐based procedures, whereas eight reports (3709 cases) described broader dermatology or cosmetic‐procedure datasets, for which laser‐related case counts were not consistently separable. Some principally laser‐focused datasets also contained non‐cutaneous procedures. Hair removal and resurfacing featured prominently in reports of cosmetic laser‐related claims. Reported injuries included burns, scarring, pigmentary changes and, less often, ocular injury. Inadequate consent, device settings, operator training and supervision featured among allegations. Broader dermatology datasets also described delayed recognition of malignant pigmented lesions, but their findings cannot be assigned specifically to laser exposure. Conclusion Published claims and case series identify recurring safety concerns during dermatologic laser and energy‐based procedures, including burns, pigmentary injury, deficient consent and inadequate supervision. Because the evidence is predominantly retrospective and often lacks procedure‐level denominators, these findings describe patterns among reported cases rather than estimating comparative litigation risk. Appropriate training, clinical assessment, supervision and documentation remain important safeguards. Prospero Registration CRD420261286979
ABSTRACT Objectives To evaluate whether dynamic optical coherence tomography (D‐OCT) vascular characteristics correlate with molecular diagnosis or laser treatment response in port wine capillary malformations. Methods D‐OCT imaging was performed in a cross‐sectional prospective of patients with clinically confirmed port wine capillary malformations. Vessel diameter was assessed using proprietary software and watershed segmentation and compared by genotype, clinical features, and treatment response. Results 47 subjects were recruited, with 173 D‐OCT images which were captured without artifact and met inclusion criterion. Quantitative vascular measurements did not differ significantly between low‐flow (GNAQ/GNA11) and fast‐flow (EPHB4/RASA1) lesions. In contrast, vessel diameters were significantly greater with laser‐resistant lesions after adjustment for confounders ( p < 0.001). Conclusions D‐OCT did not show significant genotype discrimination in this cohort but might offer a potential noninvasive biomarker for predicting laser treatment outcomes. Further prospective studies with greater power are required to validate these findings and to determine the clinical relevance for laser treatment parameters in affected patients.
ABSTRACT Objectives To determine whether integrating an artificial intelligence (AI) decision‐support system (VivoAID) into optical coherence tomography (OCT) interpretation improves diagnostic accuracy and efficiency for novice users evaluating basal cell carcinomas (BCCs). Methods Two dermatology research fellows completed a structured OCT training module for BCC identification using the VivoSight Dx system. Each independently reviewed 45 de‐identified OCT scans (31 BCC‐positive and 14 BCC‐negative, negative ones included squamous cell carcinomas, keratoacanthomas, actinic keratoses and scar tissue), with ground truth established by expert clinical interpretation and histopathology, in two sessions: one unassisted and one AI‐assisted. Session order was counterbalanced between learners, and scans were re‐randomized for AI sessions. In unassisted sessions, learners manually classified scans; in AI‐assisted sessions, they reviewed AI‐annotated scans, recorded agreement/disagreement, and noted additional findings. Time‐to‐decision per scan was measured. A linear mixed‐effects model in SAS assessed the effect of AI on decision time while accounting for scan difficulty. Results Without AI, correct BCC identification was 62% for Learner 1% and 64% for Learner 2 (combined 63%). With AI assistance, accuracy increased to 78% and 76%, respectively (combined 77%), reflecting relative improvements of 25% and 17% (combined +21%). Mean decision time decreased from 45 to 28 s for Learner 1 and from 35 to 22 s for Learner 2, yielding a combined reduction from 40 to 25 s (~38% faster). AI use significantly reduced decision time by an average of 15.1 s per image ( p < 0.0001). AI standalone accuracy versus expert opinion was 64%, comparable to novice baseline performance. Conclusions AI‐enhanced OCT with VivoAID significantly improved novice users’ diagnostic accuracy and efficiency, despite AI performance alone being similar to baseline novice interpretation. These data support VivoAID's role as a decision‐support and potential educational tool in dermatology. Findings are limited by small sample size, single‐institution design, and repeated review of the same scans. Trial Registration None.
ABSTRACT Objective To explore the feasibility of indocyanine green (ICG) near‐infrared fluorescence guidance and margin‐related outcomes in patients undergoing surgery for locally advanced oral squamous cell carcinoma (OSCC) after neoadjuvant immunotherapy. Methods This retrospective single‐center cohort included 30 consecutive patients who underwent curative‐intent surgery between May 2024 and March 2025. Fifteen underwent ICG‐guided surgery and 15 underwent conventional surgery, according to routine clinical implementation and imaging availability. The primary outcome was patient‐level positive margin status on final pathological assessment. Recorded margin‐to‐tumor distances, intraoperative margin findings and perioperative outcomes were assessed separately. Comparisons were exploratory and unadjusted. Results Tumor‐associated fluorescence was visualized in all 15 ICG‐treated patients (100%; exact 95% confidence interval [CI], 78.2%–100%). Mean recorded margin‐to‐tumor distance was 9.30 ± 1.21 mm with ICG guidance and 16.40 ± 2.41 mm with conventional surgery (mean difference, −7.10 mm; 95% CI, −8.55 to −5.65; p < 0.001). Corresponding medians were 9.0 and 16.0 mm, and minima were 8.0 and 13.0 mm. The operative summary describes additional intraoperative resection in two conventional‐group patients following frozen‐section assessment. No statistically significant between‐group differences in perioperative outcomes were detected, but confidence intervals were wide. Final pathological margin assessment identified no positive margins in either group (ICG‐guided 0/15, 0.0%; conventional 0/15, 0.0%; Fisher's exact p = 1.000). The two intraoperative frozen‐section–positive events in the conventional group were resolved to negative final margins after same‐operation resection extension. Conclusion ICG fluorescence imaging was feasible in this small retrospective cohort and was associated with shorter recorded margin‐to‐tumor distances. These findings are hypothesis‐generating and do not establish improved oncologic margin control, perioperative equivalence or functional benefit. Larger prospective studies with standardized pathological assessment and adequate follow‐up are needed.